The Czech Republic & Slovakia Affiliate of ISPE was founded in 1999. In March the Committee was established and in September 1999 the Czech Republic & Slovakia Affiliate of ISPE came officially into existence.
The Czech Republic & Slovakia Affiliate of ISPE was founded in 1999. In March the Committee was established and in September 1999 the Czech Republic & Slovakia Affiliate of ISPE came officially into existence.
Continued Process Verification (CPV) was introduced roughly 12 years ago by the FDA as a third stage in the guidance on the process validation life cycle. In addition to being...
At ISPE, our commitment to advancing the pharmaceutical industry has always revolved around delivering gold-standard Guidance Documents — a trusted source of information that...
The Facility of the Year Award (FOYA) Social Impact category recognizes companies that accelerated a shift to sustainable facility design, intended to ensure the effective use...
This training course focuses on common issues and problems in the operation of a facility and maintaining readiness for cGMP inspection. Topics include control system alarm...
Worldwide Regulatory expectations and guidance as led by FDA and the EU have stated that all Pharmaceutical Quality Systems should apply a QRM (Quality Risk Management)...
The importance and amount of data being generated to ensure product quality and patient safety continues to grow, and proper controls around that data continue to be a subject...
Join ISPE's thriving community of pharmaceutical science, engineering, and technology professionals to gain fresh perspectives, international insights, and technical expertise through virtual and in-person engagement...
Nexus Pharmaceuticals, Inc. is a woman-led, minority-owned, and family-owned healthcare company and certified diverse supplier based in Lincolnshire, Illinois, USA. Nexus is a uniquely American family company, built on...
Introducing the Future of ISPE Guidance Documents At ISPE, our mission has always been to connect knowledge, operational excellence and regulatory insights. In keeping with this commitment, we are excited to announce...
Shortages of essential medicines around the world have been an ongoing concern for patients, caregivers, and regulators and have been exacerbated by the COVID-19 pandemic. Many regulators have instituted requirements for reporting potential or actual...